Therapeutic Solutions International, Inc.
TSOI · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -1.7% | -8.3% | -8.5% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 77.6% | 66.4% | 65.7% | -693.9% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9,417.6% | -1,562.7% | -2,742.1% | -1,267.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5,123% | -1,949.7% | -2,682.4% | -1,793.7% |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | -100% | 0% | 0% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |